Please login to the form below

Not currently logged in
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Avelumab costs peg back profit at Merck KGaA

Avelumab costs peg back profit at Merck KGaA Development of its immuno-oncology product is central to Merck's healthcare plans. ... Rising costs related to the development of immuno-oncology drug avelumab ate into Merck KGaA's operating profit in the fourth quarter of 2016, and that trend looks set

BMS appoints three independent directors

BMS appoints three independent directors Since beginning his pharmaceutical career 40 years ago, Emmens has served as president, chief executive officer and chairman of Vertex Pharma, chief executive and chairman at Shire, president of Merck ... s pharmaceutical division, and president and

Novartis' Zykadia nears first-line lung cancer label

Novartis' Zykadia nears first-line lung cancer label Zykadia was first approved in 2015 as a second-line option for ALK-positive NSCLC patients whose disease had progressed despite earlier treatment with Pfizer/Merck KGaA's rival ALK inhibitor

Deal Watch January 2017

Deal Watch January 2017 Merck KGaA / Palantir. Combining Merck's research with other bioinformatics for patient sub group identification. ... 250. Vertex. Merck KGaA. Collaboration. VX 970 VX 803 and 2 others ATR inhibitors.

Opdivo drives growth at BMS, but US sales slow down

Opdivo drives growth at BMS, but US sales slow down first-line non-small cell lung cancer (NSCLC), handing an advantage to Merck &Co's rival therapy Keytruda (pembrolizumab). ... least in part to the Opdivo effect and the prospect of competition from new immuno-oncology drugs from the likes of Roche,

[ Previous 5 results ] 19 20 21 22 23 24 25 26 27 28 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...